Cas:1158525-58-6 Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride manufacturer & supplier

We serve Chemical Name:Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride CAS:1158525-58-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride

Chemical Name:Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride
CAS.NO:1158525-58-6
Synonyms:Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride
Molecular Formula:C11H18Cl2N2O
Molecular Weight:265.18
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride Use and application,Pyridin-3-ylmethyl-(tetrahydro-pyran-4-yl)-amine dihydrochloride technical grade,usp/ep/jp grade.


Related News: The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. 2-Isopropyl-3-methylthiomorpholine manufacturers Results from a Phase I clinical trial, published in The Lancet, found that two-doses of the inhaled Ad5-nCoV vaccine can trigger a similar immune response to a single-dose of the injected version. 2-(4-phenoxyphenyl)acetaldehyde suppliers in addition to standard therapy. The trial did not meet its primary endpoint based on the SLE Responder Index 4 (SRI4) composite measure. 1-(2-Bromophenyl)piperidine vendor & factory.